NeuroSense Therapeutics (NRSN) Q1 2024 Earnings

5AprConfirmed
Q1 2023
Q2 2023
Q3 2023
Q1 2024
-0.28
-0.15
-0.03
0.1

Details

Expected EPS
-0.23
Actual EPS
-0.16
Surprise EPS
0.07
Surprise Percent
+30.43%

Description

NeuroSense Therapeutics (NRSN) has reported earnings of -0.16 per share for Q1 2024.

0 Comments

Share your thoughts